Bain Capital Life Sciences

Executive Summary

Bain Capital Life Sciences, founded in 2016, is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools. With over $7 billion in assets under management and a team of experts with deep industry and scientific insights, they aim to build a diverse portfolio of high-impact companies addressing unmet medical needs.

• Assets under management: $7 billion+
• Investments globally: 70+
• Medicines or technologies approved or launched: 20+

Snapshot

Fund Size	N/A USD
Stages Focus	Early-Stage, Growth, Later-Stage
Sectors Focus	Pharmaceuticals, Biotechnology, Medical Devices, Diagnostics, Life Science Tools
Portfolio Size	4 companies

Investment Thesis

Bain Capital Life Sciences is committed to investing in transformative technologies and therapies within the healthcare and life sciences sectors. Their investment approach is grounded in a science-first diligence process, ensuring that each investment has the potential to make a significant impact on patient lives. They seek to build a diverse portfolio of high-impact, high-value-creating companies by adhering to their guiding principles.

• Target Founders: Entrepreneurs with a vision for transformative healthcare solutions.
• Sectors: Pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.
• Stage: Investments span from early-stage to growth and later-stage opportunities.
• Check Size: Early-stage investments typically range from $5M to $20M, with larger checks for growth and later-stage investments.
• Geography: Global investments with a focus on companies addressing unmet medical needs.
• Deal Criteria: Emphasis on innovative solutions with the potential for significant impact on patient lives.

Team & Activity

Active team contains 3 members (3 partners, 0 founders).

Frequently Asked Questions

• What is Bain Capital Life Sciences?
  

  Bain Capital Life Sciences is a dedicated investment firm focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.

• Where is Bain Capital Life Sciences located?
  

  Bain Capital Life Sciences is located in Boston, United States.

• When was Bain Capital Life Sciences founded?
  

  Bain Capital Life Sciences was founded in 2016.

• What type of investor is Bain Capital Life Sciences?
  

  Bain Capital Life Sciences is a venture capital firm.

• What is the typical check size for Bain Capital Life Sciences?
  

  The typical check size for Bain Capital Life Sciences is $12,500,000 USD.

• Does Bain Capital Life Sciences accept cold outreach?
  

  No, Bain Capital Life Sciences does not accept cold outreach.

• Who are some key team members at Bain Capital Life Sciences?
  

  Key team members at Bain Capital Life Sciences include Allyson S. Rinderle, Ricky Lijing Sun, and Matthew Calistri.

• What is the summary of Bain Capital Life Sciences?
  

  Bain Capital Life Sciences is a dedicated investment firm founded in 2016, focused on driving medical innovation across pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.

• Does Bain Capital Life Sciences invest in Pharmaceuticals?
  

  Yes, Bain Capital Life Sciences invests in Pharmaceuticals.

• Does Bain Capital Life Sciences invest in Biotechnology?
  

  Yes, Bain Capital Life Sciences invests in Biotechnology.

Related Investors

• Standard Crypto (Similarity: 20%)
• ACS BrightEdge (Similarity: 20%)
• DaVita Venture Group (Similarity: 16%)
• Alzheimer's Drug Discovery Foundation (Similarity: 16%)
• Logos Capital (Similarity: 16%)
• RoboStrategy (Similarity: 13%)
• Bungalow (Similarity: 13%)
• FTV (Similarity: 13%)
• Spire Capital (Similarity: 13%)
• Square (Similarity: 13%)